Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,876 | 19,159 | 5,749 | 1,823 | 6,101 |
| Receivables | 3,059 | 3,393 | 4,119 | 4,749 | 8,760 |
| Inventories | 11,157 | 12,592 | 11,932 | 12,192 | 10,995 |
| TOTAL | $35,110 | $36,047 | $22,894 | $19,969 | $27,019 |
| Non-Current Assets | |||||
| PPE Net | 782 | 742 | 781 | 1,017 | 1,193 |
| Intangibles | 2,926 | 2,926 | 2,926 | 2,926 | 2,926 |
| Other Non-Current Assets | 2,207 | 2,281 | 1,155 | 619 | 709 |
| TOTAL | $5,915 | $5,949 | $4,862 | $4,562 | $4,828 |
| Total Assets | $41,025 | $41,996 | $27,756 | $24,531 | $31,847 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 12,946 | 13,544 | 13,562 | 13,466 |
| Accounts payable and accrued liabilities | 2,651 | 2,592 | 2,510 | 4,056 | 5,332 |
| Accrued Expenses | 6,667 | 4,279 | 3,549 | 4,079 | 4,744 |
| TOTAL | $11,223 | $21,433 | $21,089 | $23,679 | $25,779 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,186 | 3,140 | 3,140 | N/A | N/A |
| Deferred Revenues | 1,905 | 1,616 | 1,486 | 1,982 | 2,237 |
| Other Non-Current Liabilities | 3,214 | 3,160 | 1,806 | 1,353 | 1,368 |
| TOTAL | $19,774 | $6,712 | $5,358 | $1,743 | $1,726 |
| Total Liabilities | $30,997 | $28,145 | $26,447 | $25,422 | $27,505 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60 | 37 | 37 | 13 | 13 |
| Common Shares | 98 | 93 | 50 | 32 | 31 |
| Retained earnings | -251,376 | -245,234 | -245,251 | -240,553 | -234,547 |
| Other shareholders' equity | -385 | -534 | -645 | -719 | -701 |
| TOTAL | $10,028 | $13,851 | $1,309 | $-891 | $4,342 |
| Total Liabilities And Equity | $41,025 | $41,996 | $27,756 | $24,531 | $31,847 |